4
Changes in Ownership
PLIANT THERAPEUTICS, INC. Filed Acc 0001746473-24-000014
Chief Financial Officer acquired 55,250 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cummings Keith Lamont Chief Financial Officer | 2024-01-23 | Grant or award | +55,250 | 249,855 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Cummings Keith Lamont Chief Financial Officer | 2024-01-23 | Grant or award · Stock Option (Right to Buy) | +110,500 | 110,500 | D: show line 2 in the form |
Loading xslF345X05/wk-form4_1706133428.xml…